News from the 2010 EASL conference

For anyone interested, the Janus7 website has been reporting the presentations at the April 14-18 EASL conference and the news is exciting. There are many companies reporting results of tests in vitro and in vivo that are very potent against the HEP C virus. What is so promising is that there are now several protease inhibitors as well as polymerase inhibitors and non-nucleoside inhibitors that work against ALL genotypes. Pharmassett, IDNX and Vertex are all testing 3 different kind of inhibitors WITHOUT interferon and all of them are convinced the future SOC will be oral combinations without interferon.

[robo229]

Great news!

Can you please provide some links to these encouraging reports?  

If we stop referring to Interferon/Ribavirin as SOC, they are more likely to fade away.  Medical practiotioners are loathe to disregard "Standard of Care" for fear of liability or peer criticism. Anyone who has tried it can attest to it's toxic side effects, hardly the desired standard.

Robo

[tashka]

This is very exciting! Thank you for posting. Can you, please, post the links? I would like to read more on this.

[burned74]

HCVadvocate also has updates on the conference